ConductScience.org, home

Paper8538748

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.

Graeber TG and 6 others. Nature, 1996. Cited by 2,051 papers, by iCite.

Cite this record

ConductScience Library. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Papers, record 8538748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8538748

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
PubMed
Journal
Nature
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
2,051
iCite
Relative citation ratio, by iCite
46.9
iCite
Revised in PubMed
2022-03-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Graeber TGT G
2Osmanian CC
3Jacks TT
4Housman DED E
5Koch CJC J
6Lowe SWS W
7Giaccia AJA J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
NeoplasmsMajor topic
OxygenMajor topic
Animals
Cell Hypoxia
Cell Line, Transformed
Cell Transformation, Neoplastic
Genes, p53
Mice
Neoplasm Transplantation
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-myc
Rats
Receptors, Estrogen
Tamoxifen

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in8538735Life (and death) in a malignant tumour.https://conductscience.org/library/papers/8538735PubMed
Comment in8600376Little difference.https://conductscience.org/library/papers/8600376PubMed

Download CSV of comments and corrections

Cited by656

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,051 citations.

PMIDTitleJournalYearIn PapersSource
42506076Neuromodulation in Neuro-Oncology: A Scoping Review.J Pers Med2026https://conductscience.org/library/papers/42506076PubMed
42286021Endoglin (CD105) overexpression is associated with an immunosuppressive tumor microenvironment in murine lung cancer models and human lung adenocarcinoma.Sci Rep2026https://conductscience.org/library/papers/42286021PubMed
41900967Pathogenic Mechanisms in Cervical Cancer: Energy Metabolism, Hypoxia and Therapy.Life (Basel)2026https://conductscience.org/library/papers/41900967PubMed
41898553The Significance of CXCL1 in Cancer: An Overview of Molecular Mechanisms.Int J Mol Sci2026https://conductscience.org/library/papers/41898553PubMed
41526628Prognostic Value of Preoperative Anemia on Survival and Recurrence in Patients with Bladder Carcinoma Treated by Radical Cystectomy.Ann Surg Oncol2026https://conductscience.org/library/papers/41526628PubMed
41369841Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective.J Mammary Gland Biol Neoplasia2025https://conductscience.org/library/papers/41369841PubMed
41171287ROSBASE1.0: a comprehensive database of reactive oxygen species (ROS): categorization of cell organelles, proteins, taxonomy, and diseases based on ROS-related activities.Database (Oxford)2025https://conductscience.org/library/papers/41171287PubMed
41057692A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma.Nat Cancer2025https://conductscience.org/library/papers/41057692PubMed
40964288Tumor nutrient stress gives rise to a drug tolerant cell state in pancreatic cancer.bioRxiv2025https://conductscience.org/library/papers/40964288PubMed
40447954Tumor hypoxia shapes natural killer cell anticancer activities.J Mol Med (Berl)2025https://conductscience.org/library/papers/40447954PubMed
40005071Coenzyme Q10 as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs.Molecules2025https://conductscience.org/library/papers/40005071PubMed
39966387Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.Cell Death Discov2025https://conductscience.org/library/papers/39966387PubMed
39875616Tumour hypoxia in driving genomic instability and tumour evolution.Nat Rev Cancer2025https://conductscience.org/library/papers/39875616PubMed
39682147Machine Perfusion as a Strategy to Decrease Ischemia-Reperfusion Injury and Lower Cancer Recurrence Following Liver Transplantation.Cancers (Basel)2024https://conductscience.org/library/papers/39682147PubMed
39627312An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis.Sci Rep2024https://conductscience.org/library/papers/39627312PubMed
39236027Identifying crucial lncRNAs and mRNAs in hypoxia-induced A549 lung cancer cells and investigating their underlying mechanisms via high-throughput sequencing.PLoS One2024https://conductscience.org/library/papers/39236027PubMed
39201609Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets.Int J Mol Sci2024https://conductscience.org/library/papers/39201609PubMed
38697993NREP, transcriptionally upregulated by HIF-1α, aggravates breast cancer cell growth and metastasis by promoting glycolysis.Cell Death Discov2024https://conductscience.org/library/papers/38697993PubMed
38487001Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.Acta Pharm Sin B2024https://conductscience.org/library/papers/38487001PubMed
38398017Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.Biomedicines2024https://conductscience.org/library/papers/38398017PubMed

See all 656 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8538748

GET https://conductscience.org/api/papers/v1/8538748/cited_by?page=2